Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial-Reference-Cited by-同舟云学术

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial

Published:2012-10 Issue:10 Volume:13 Page:1055-1062
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Eisen Tim,Joensuu Heikki,Nathan Paul D,Harper Peter G,Wojtukiewicz Marek Z,Nicholson Steve,Bahl Amit,Tomczak Piotr,Pyrhonen Seppo,Fife Kate,Bono Petri,Boxall Jane,Wagner Andrea,Jeffers Michael,Lin Tiffany,Quinn David I

Publisher

Elsevier BV

Subject

Oncology

Reference20 articles.

1. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Escudier;Ann Oncol,2010

2. The medical management of metastatic renal cell carcinoma: integrating new guidelines and recommendations;Bellmunt;BJU Int,2009

3. Epidemiology of renal cell carcinoma;Lindblad;Scand J Surg,2004

4. Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma;McDermott;J Clin Oncol,2005

5. EORTC-GU group expert opinion on metastatic renal cell cancer;de Reijke;Eur J Cancer,2009

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small-molecule-based targeted therapy in liver cancer;Molecular Therapy;2024-08

2. A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors;Anti-Cancer Drugs;2024-03-08

3. Rearranged during transfection (RET) inhibitors;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024

4. Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database;Biomedicines;2023-08-20

5. Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma;Journal of Experimental & Clinical Cancer Research;2023-04-03